Abbott Amplatzer Paraclose PVL Occluder Wins FDA Approval
Abbott announced on October 28, 2026, that it has received U.S. Food and Drug Administration approval for the Amplatzer Paraclose PVL Occluder, a transcatheter device designed to treat paravalvular leak (PVL), a backflow of blood around a surgical heart valve. In its announcement, Abbott describes the implant as the first and only transcatheter device approved in the U.S. specifically designed to treat PVL, giving physicians a minimally invasive option to close these leaks without requiring…